Category: PSA Screening

A diabetic man aged 76 with no history of prostate cancer (PCa) comes to his primary care physician (PCP) for his annual wellness visit. (Sidebar: in the good old days they were called physicals, but in today’s Medicare world, they’re annual wellness visits—and yes, there is a difference but that’s for another day.) He fasted keep reading

Not long ago, I posted a blog on the ability of androgen deprivation therapy (ADT) to boost the effectiveness of radiation therapy for prostate cancer. This synergistic effect is very important for men with intermediate or higher risk cancer who can’t have (or don’t want) radical prostatectomy, since the greater the risk, the more likely keep reading

Prostate specific antigen (PSA) is like an ID tag for prostate cells. Each prostate cell, whether normal or cancerous, carries proteins (antigens) that can be “shed” into the bloodstream when some type of activity stimulates the prostate. Generally, the more constant the activity, the higher the level of PSA as measured by a simple blood keep reading

Does PSA screening reduce prostate cancer mortality or not? The debate rages on, but here's the latest and most thorough science... keep reading

The New York Times, like all news media, is a vehicle to air conflicting views. The November 25, 2014 issue ran a strongly-worded editorial opinion piece by Richard Ablin, PhD, the self-proclaimed “discoverer of PSA”... keep reading